Close Menu

NEW YORK (GenomeWeb) – Opko Health yesterday reported a massive jump in third quarter revenues as the company benefitted from its recent acquisitions of clinical lab Bio-Reference Laboratories and specialty pharmaceutical manufacturer EirGen earlier this year.

For the three-month period ended Sept. 30, Miami, Florida-based Opko reported consolidated revenues of $143 million compared with $19.8 million in the same period last year, in line with analysts' consensus estimate. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.